Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Rho regulates p21CIP1, cyclin D1, and checkpoint control in mammary epithelial cells

Abstract

The small GTPase Rho is important for cell cycle progression and Ras transformation in fibroblasts. However, it is unclear whether Rho is needed for proliferation in other cell types, and its targets in promoting normal cell cycle progression are unknown. Here, we demonstrate that Rho is required for G1 to S progression in MCF10A mammary epithelial cells, both in response to EGF and in response to oncogenic Ras. We describe two effects of Rho, the repression of p21CIP1 and the induction of cyclin D1, that may underlie its role in promoting S phase entry. The Rho inhibitor, C3 exotransferase, induced p21CIP1 both in EGF-stimulated and V12Ras-expressing cells. In addition, C3 blocked EGF-stimulated cyclin D1 promoter activity whereas V14RhoA induced the cyclin D1 promoter and cooperated with V12Ras in cyclin D1 induction. Finally, a high proportion of cells co-expressing V14RhoA and V12Ras displayed lobulated, polyploid nuclei that were actively synthesizing DNA. Our results demonstrate that Rho plays a fundamental role in promoting Ras-dependent S phase entry in mammary epithelial cells, whether in response to normal or oncogenic signaling, and indicate that in cells expressing oncogenic Ras, the activation of Rho diminishes p21CIP1 expression, increases cyclin D1 promoter activity, and uncouples DNA synthesis from mitosis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Aktories K, Just I . 1995 Methods Enzymol. 256: 184–195

  • Albanese C, Johnson J, Watanabe G, Eklund N, Vu D, Arnold A, Pestell RG . 1995 J. Biol. Chem. 270: 23589–23597

  • Barbacid M . 1987 Annu. Rev. Biochem. 56: 779–827

  • Bartkova J, Lukas J, Muller H, Lutzhoft D, Strauss M, Bartek J . 1994 Int. J. Cancer 57: 353–361

  • Cerione RA, Zheng Y . 1996 Curr. Opin. Cell. Biol. 8: 216–222

  • Dulic V, Stein GH, Far DF, Reed SI . 1998 Mol. Cell. Biol. 18: 546–557

  • Eva A, Aaronson SA . 1985 Nature 316: 273–275

  • Gillett C, Fantl V, Smith R, Fisher C, Bartek J, Dickson C, Barnes D, Peters G . 1994 Cancer Res. 54: 1812–1817

  • Gudas Nguyen H, Li T, Hill D, Cowan KH . 1995 Oncogene 11: 253–261

  • Joyce D, Bouzahzah B, Fu M, Albanese C, D'Amico M, Steer J, Klein JU, Lee RJ, Segall JE, Westwick JK, Der CJ, Pestell RG . 1999 J. Biol. Chem. 274: 25245–25249

  • Kerkhoff E, Rapp UR . 1998a Oncogene 17: 1457–1462

  • Kerkhoff E, Rapp UR . 1998b Cancer Res. 58: 1636–1640

  • Khosravi-Far R, Campbell S, Rossman KL, Der CJ . 1997 Advances Cancer Res. 72: 72–107

  • Kortenjann M, Thomae O, Shaw PE . 1994 Mol. Cell. Biol. 14: 4815–4824

  • Lee RJ, Albanese C, Fu M, D'Amico M, Lin B, Watanabe G, Haines III GK, Siegel PM, Hung MC, Yarden Y, Horowitz JM, Muller WJ, Pestell RG . 2000 Mol. Cell. Biol. 20: 672–683

  • Li Y, Jenkins CW, Nichols MA, Xiong Y . 1994 Oncogene 9: 2261–2268

  • Liberto M, Cobrinik D . 2000 Cancer Lett. 154: 151–161

  • Lin R, Cerione RA, Manor D . 1999 J. Biol. Chem. 274: 23633–23641

  • Macleod KF, Sherry N, Hannon G, Beach D, Tokino T, Kinzler K, Vogelstein B, Jacks T . 1995 Genes Dev. 9: 935–944

  • Mantel C, Braun SE, Reid S, Henegariu O, Liu L, Hangoc G, Broxmeyer HE . 1999 Blood 93: 1390–1398

  • Marshall C . 1995 Cell 80: 179–185

  • Michieli P, Chedid M, Lin D, Pierce JH, Mercer WE, Givol D . 1994 Cancer Res. 54: 3391–3395

  • Minden A, Lin A, Claret FX, Abo A, Karin M . 1995 Cell 81: 1147–1157

  • Niculescu III AB, Chen X, Smeets M, Hengst L, Prives C, Reed SI . 1998 Mol. Cell. Biol. 18: 629–643

  • Nobes CD, Hall A . 1995 Cell 81: 53–62

  • Olson MF, Ashworth A, Hall A . 1995 Science 269: 1270–1272

  • Olson MF, Paterson HF, Marshall CJ . 1998 Nature 394: 295–299

  • Pagano M, Tam SW, Theodoras AM, Beer-Romero P, Del Sal G, Chau V, Yew PR Draetta GF, Rolfe M . 1995 Science 269: 682–685

  • Page K, Li J, Hodge JA, Liu PT, Vanden Hoek TL, Becker LB, Pestell RG, Rosner MR, Hershenson MB . 1999 J. Biol. Chem. 274: 22065–22071

  • Prendergast GC, Khosravi-Far R, Solski PA, Kurzawa H, Lebowitz P, Der CJ . 1995 Oncogene 10: 2289–2296

  • Qiu RG, Abo A, McCormick F, Symons M . 1997 Mol. Cell. Biol. 17: 3449–3458

  • Qiu RG, Chen J, Kirn D, McCormick F, Symons M . 1995a Nature 374: 457–459

  • Qiu RG, Chen J, McCormick F, Symons M . 1995b Proc. Natl. Acad. Sci. USA 92: 11781–11785

  • Ron D, Tronick SR, Aaronson SA, Eva A . 1988 EMBO J. 7: 2465–2473

  • Sahai E, Ishizaki T, Narumiya S, Treisman R . 1999 Curr. Biol. 9: 136–145

  • Sicinski P, Weinberg RA . 1997 J. Mammary Gland Biol. Neoplasia. 2: 335–342

  • Soule HD, Maloney TM, Wolman SR, Peterson Jr WD, Brenz R, McGrath CM, Russo J, Pauley RJ, Jones RF, Brooks SC . 1990 Cancer Res. 50: 6075–6086

  • Stewart ZA, Leach SD, Pietenpol JA . 1999 Mol. Cell. Biol. 19: 205–215

  • Tombes RM, Auer KL, Mikkelsen R, Valerie K, Wymann MP, Marshall CJ, McMahon M, Dent P . 1998 Biochem. J. 330: 1451–1460

  • Troppmair J, Bruder JT, Munoz H, Lloyd PA, Kyriakis J, Banerjee P, Avruch J, Rapp UR . 1994 J. Biol. Chem. 269: 7030–7035

  • Van Aelst L, D'Souza-Schorey C . 1997 Genes Dev. 11: 2295–2322

  • Waldman T, Lengauer C, Kinzler KW, Vogelstein B . 1996 Nature 381: 713–716

  • Westwick JK, Lambert GT, Clark GJ, Symons M, Van Aelst L, Pestell RG, Der CJ . 1997 Mol. Cell. Biol. 17: 1324–1335

  • Westwick JK, Lee RJ, Lambert QT, Symons M, Pestell RG, Der CJ, Whitehead IP . 1998 J. Biol. Chem. 273: 16739–16747

  • Woods D, Parry D, Cherwinski H, Boxch E, Lees E, McMahon M . 1997 Mol. Cell. Biol. 17

  • Yamamoto M, Marui N, Sakai T, Morii N, Kozaki S, Ikai K, Imamura S, Narumiya S . 1993 Oncogene 8: 1449–1455

  • Yu Q, Geng Y, Sicinski P . 2001 Nature 411: 1017–1021

  • Zhou P, Jiang W, Weghorst CM, Weinstein IB . 1996 Cancer Res. 56: 36–39

Download references

Acknowledgements

We thank Richard Pestell for the Cyclin D1 promoter construct. This work was supported by R01 CA76342 and an American Scientist Development Grant Award from the American Heart Association to A Minden and DAMD17-98-1-8051 from the United States Army Breast Cancer Research Program to D Cobrinik

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to David Cobrinik or Audrey Minden.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liberto, M., Cobrinik, D. & Minden, A. Rho regulates p21CIP1, cyclin D1, and checkpoint control in mammary epithelial cells. Oncogene 21, 1590–1599 (2002). https://doi.org/10.1038/sj.onc.1205242

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205242

Keywords

This article is cited by

Search

Quick links